13 min listen
Aditya Bardia, MD - Endocrine Sensitivity in the Real World: Practical Guidance to Optimize Second-Line Care in ER-Positive, HER2-Negative Advanced Br…
Aditya Bardia, MD - Endocrine Sensitivity in the Real World: Practical Guidance to Optimize Second-Line Care in ER-Positive, HER2-Negative Advanced Br…
ratings:
Length:
20 minutes
Released:
Mar 29, 2024
Format:
Podcast episode
Description
Please visit answersincme.com/GTJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in breast cancer discusses endocrine receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer. Upon completion of this activity, participants should be better able to: Review how the evolving concept of ER sensitivity is relevant to therapeutic decision-making in patients with ER-positive, HER2-negative advanced breast cancer; Describe the clinical profiles of approved and emerging therapeutic options for ER-positive, HER2-negative advanced breast cancer post–cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor use; Identify clinical strategies to optimize the integration of mutational testing into practice for ER-positive, HER2-negative advanced breast cancer; and Outline a personalized approach to therapeutic decision-making to enhance real-world outcomes in ER-positive, HER2-negative advanced breast cancer after initial CDK4/6 inhibitor therapy.
Released:
Mar 29, 2024
Format:
Podcast episode
Titles in the series (84)
Stephen Lam Chan, MD - Recalibrating Survival: Available and Recently Approved Immunotherapy-Based Combination Approaches in Unresectable HCC: Please visit answersincme.com/TZQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology